Review of Community Pharmacy Staff Educational Needs for Supporting Mental Health Consumers and Carers

Overview

Journal Community Ment Health J

Specialty Health Services

Date 2013 Jan 12

PMID 23306675

Citations 9

Authors

Amary Mey

Jane L Fowler

Kathy Knox

David H K Shum

Jasmina Fejzic

Laetitia Hattingh

Denise McConnell

Amanda Wheeler

Affiliations

Soon will be listed here.

Abstract

Development of a mental health education package for community pharmacy staff should be informed by mental health consumers/carers' needs, expectations and experiences, and staff knowledge, skills and attitudes. This review (1) explored research on community pharmacy practice and service provision for mental health consumers/carers, and (2) identified validated methods for assessing staff knowledge, skills and attitudes about mental illness to inform the development of a training questionnaire. A literature scan using key words knowledge, skills, attitudes, and beliefs combined with community pharmacy, pharmacist, and pharmacy support staff, and mental illness, depression, anxiety was conducted. A small number of studies were found that used reliable methods to assess pharmacists' training needs regarding mental illness and treatment options. There was little published specifically in relation to depression and anxiety in community pharmacy practice. No studies assessed the training needs of pharmacy support staff. A systematic analysis of pharmacy staff learning needs is warranted.

Citing Articles

Global Advancement in Pharmacy Services for Mental Health: A Review for Evidence-Based Practices.

Alshammari M, Alotaibi N, Al Suroor S, Al Saed R, Al-Hamoud A, Alluwaif M Healthcare (Basel). 2023; 11(8).

PMID: 37107916 PMC: 10137606. DOI: 10.3390/healthcare11081082.

How is mental health care provided through community pharmacies? A quest for improvement.

Samorinha C, Saidawi W, Saddik B, Abduelkarem A, Alzoubi K, Abu-Gharbieh E Pharm Pract (Granada). 2022; 20(2):2648.

PMID: 35919799 PMC: 9296078. DOI: 10.18549/PharmPract.2022.2.2648.

Patient care activities by community pharmacists in a capitation funding model mental health and addictions program.

Murphy A, Gardner D, Jacobs L BMC Psychiatry. 2018; 18(1):192.

PMID: 29898682 PMC: 6000927. DOI: 10.1186/s12888-018-1746-3.

Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs.

Giannetti V, Caley C, Kamal K, Covvey J, McKee J, Wells B Int J Clin Pharm. 2018; 40(5):1096-1105.

PMID: 29862460 DOI: 10.1007/s11096-018-0619-7.

Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service.

Maulavizada H, Emmerton L, Hattingh H BMC Health Serv Res. 2016; 16:146.

PMID: 27112344 PMC: 4845305. DOI: 10.1186/s12913-016-1406-6.

References

Hammond R, Schwartz A, Campbell M, Remington T, Chuck S, Blair M . Collaborative drug therapy management by pharmacists--2003. Pharmacotherapy. 2003; 23(9):1210-25. DOI: 10.1592/phco.23.10.1210.32752. View

Gilbert A, Roughead E, Beilby J, Mott K, Barratt J . Collaborative medication management services: improving patient care. Med J Aust. 2002; 177(4):189-92. DOI: 10.5694/j.1326-5377.2002.tb04730.x. View

Jorm A, Korten A, Jacomb P, Christensen H, Henderson S . Attitudes towards people with a mental disorder: a survey of the Australian public and health professionals. Aust N Z J Psychiatry. 1999; 33(1):77-83. DOI: 10.1046/j.1440-1614.1999.00513.x. View

Nordt C, Rossler W, Lauber C . Attitudes of mental health professionals toward people with schizophrenia and major depression. Schizophr Bull. 2006; 32(4):709-14. PMC: 2632277. DOI: 10.1093/schbul/sbj065. View

Scheerder G, Van Audenhove C, Arensman E, Bernik B, Giupponi G, Horel A . Community and health professionals' attitude toward depression: a pilot study in nine EAAD countries. Int J Soc Psychiatry. 2010; 57(4):387-401. DOI: 10.1177/0020764009359742. View

Scheerder G, De Coster I, Van Audenhove C . Pharmacists' role in depression care: a survey of attitudes, current practices, and barriers. Psychiatr Serv. 2008; 59(10):1155-60. DOI: 10.1176/ps.2008.59.10.1155. View

Van Wijk B, Klungel O, Heerdink E, de Boer A . Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother. 2005; 39(2):319-28. DOI: 10.1345/aph.1E027. View

Angermeyer M, Matschinger H . The stigma of mental illness: effects of labelling on public attitudes towards people with mental disorder. Acta Psychiatr Scand. 2003; 108(4):304-9. DOI: 10.1034/j.1600-0447.2003.00150.x. View

Benrimoj S, Frommer M . Community pharmacy in Australia. Aust Health Rev. 2004; 28(2):238-46. DOI: 10.1071/ah040238. View

10.

Angermeyer M, Dietrich S . Public beliefs about and attitudes towards people with mental illness: a review of population studies. Acta Psychiatr Scand. 2006; 113(3):163-79. DOI: 10.1111/j.1600-0447.2005.00699.x. View

11.

Gisev N, Bell J, OReilly C, Rosen A, Chen T . An expert panel assessment of comprehensive medication reviews for clients of community mental health teams. Soc Psychiatry Psychiatr Epidemiol. 2009; 45(11):1071-9. DOI: 10.1007/s00127-009-0148-8. View

12.

Phokeo V, Sproule B, Raman-Wilms L . Community pharmacists' attitudes toward and professional interactions with users of psychiatric medication. Psychiatr Serv. 2004; 55(12):1434-6. DOI: 10.1176/appi.ps.55.12.1434. View

13.

Kobau R, DiIorio C, Chapman D, Delvecchio P . Attitudes about mental illness and its treatment: validation of a generic scale for public health surveillance of mental illness associated stigma. Community Ment Health J. 2009; 46(2):164-76. DOI: 10.1007/s10597-009-9191-x. View

14.

McCall L, Clarke D, Rowley G . A questionnaire to measure general practitioners' attitudes to their role in the management of patients with depression and anxiety. Aust Fam Physician. 2002; 31(3):299-303. View

15.

Scheerder G, De Coster I, Van Audenhove C . Community pharmacists' attitude toward depression: a pilot study. Res Social Adm Pharm. 2009; 5(3):242-52. DOI: 10.1016/j.sapharm.2008.08.008. View

16.

Bell S, McLachlan A, Aslani P, Whitehead P, Chen T . Community pharmacy services to optimise the use of medications for mental illness: a systematic review. Aust New Zealand Health Policy. 2005; 2:29. PMC: 1345690. DOI: 10.1186/1743-8462-2-29. View

17.

Finley P, Crismon M, Rush A . Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy. 2003; 23(12):1634-44. DOI: 10.1592/phco.23.15.1634.31952. View

18.

Slade T, Johnston A, Oakley Browne M, Andrews G, Whiteford H . 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Aust N Z J Psychiatry. 2009; 43(7):594-605. DOI: 10.1080/00048670902970882. View

19.

Priest R, Vize C, Roberts A, Roberts M, Tylee A . Lay people's attitudes to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch. BMJ. 1996; 313(7061):858-9. PMC: 2359082. DOI: 10.1136/bmj.313.7061.858. View

20.

Bell J, Aaltonen S, Airaksinen M, Volmer D, Gharat M, Muceniece R . Determinants of mental health stigma among pharmacy students in Australia, Belgium, Estonia, Finland, India and Latvia. Int J Soc Psychiatry. 2009; 56(1):3-14. DOI: 10.1177/0020764008097621. View